Search results for: Innovation Policy Prize
Filter search results
OHE at the Health Economists’ Study Group (HESG) Meeting, Manchester 2016
4 January 2016
…2009, issued supplementary advice to its advisory committees regarding the appraisal of life-extending end of life treatments. NICE’s policy places additional weight on the survival benefits for patients with short…
Incentives for R&D: Payment Options and Pricing Challenges
8 January 2020
The issue of rising prescription drug prices is a concern in every country. Dozens of policy initiatives and hundreds of research projects over last the fifty years have attempted to…
New OHE research finds productivity losses from respiratory infections cost UK businesses £44 billion per year
16 December 2024
…total costs. The burden of respiratory infections is disproportionately higher for women and varies across business sectors. The UK’s trailing productivity growth rate relative to other G7 economies has prompted policymakers to give a…
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
2 June 2023
…savings, and is associated with broader elements of value The barriers to widespread access include lack of funding, inefficient testing infrastructure, and variation in guidance To improve uptake, policymakers should…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies
8 January 2020
…policy hurdles related to evidence development and acceptance, value assessment and reimbursement pathways,… Histology independent therapies, a new class of medicines that target cancer based on specific genomic or molecular…
Neil Grubert
12 January 2026
Neil Grubert has more than 25 years’ experience in market access and policy. He spearheaded the development of Decision Resources Group’s international market access business, most recently as Vice President…
OHE at EuHEA 2016: Opportunity Costs, Value Based Pricing, Economies of Scope and Quality of Life
17 August 2016
…to differ cross-nationally with per capita income. To apply such a policy of VBDPs in the EU would enhance access to drugs and overall welfare. It could be done via…
Disability Adjusted Life Years (DALYs) for Decision-Making?
9 January 2002
Disability-adjusted life years (DALYs) were introduced in 1993 amid the pages and policy directives of the World Development Report ‘Investing in Health’ (World Bank, 1993). DALYs are a measure of…
Eliciting the Relative Value of Life Extension at the End of Life
29 November 2016
…the preference elicitation literature on end of life, it would seem to offer good evidence of plurality in public views – raising issues for future research and policy. Published article:…